1. Home
  2. IMMP vs FCCO Comparison

IMMP vs FCCO Comparison

Compare IMMP & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • FCCO
  • Stock Information
  • Founded
  • IMMP 1987
  • FCCO 1994
  • Country
  • IMMP Australia
  • FCCO United States
  • Employees
  • IMMP N/A
  • FCCO N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • FCCO Major Banks
  • Sector
  • IMMP Health Care
  • FCCO Finance
  • Exchange
  • IMMP Nasdaq
  • FCCO Nasdaq
  • Market Cap
  • IMMP 211.1M
  • FCCO 182.4M
  • IPO Year
  • IMMP N/A
  • FCCO 1998
  • Fundamental
  • Price
  • IMMP $1.78
  • FCCO $23.10
  • Analyst Decision
  • IMMP Buy
  • FCCO Strong Buy
  • Analyst Count
  • IMMP 1
  • FCCO 2
  • Target Price
  • IMMP $7.00
  • FCCO $30.00
  • AVG Volume (30 Days)
  • IMMP 150.7K
  • FCCO 22.6K
  • Earning Date
  • IMMP 02-27-2025
  • FCCO 07-16-2025
  • Dividend Yield
  • IMMP N/A
  • FCCO 2.59%
  • EPS Growth
  • IMMP N/A
  • FCCO 37.48
  • EPS
  • IMMP N/A
  • FCCO 1.98
  • Revenue
  • IMMP $3,019,249.00
  • FCCO $67,933,000.00
  • Revenue This Year
  • IMMP $50.37
  • FCCO $18.61
  • Revenue Next Year
  • IMMP N/A
  • FCCO $11.88
  • P/E Ratio
  • IMMP N/A
  • FCCO $11.79
  • Revenue Growth
  • IMMP 24.11
  • FCCO 16.46
  • 52 Week Low
  • IMMP $1.32
  • FCCO $15.75
  • 52 Week High
  • IMMP $2.86
  • FCCO $27.96
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 44.44
  • FCCO 43.62
  • Support Level
  • IMMP $1.88
  • FCCO $23.33
  • Resistance Level
  • IMMP $1.94
  • FCCO $23.84
  • Average True Range (ATR)
  • IMMP 0.12
  • FCCO 0.54
  • MACD
  • IMMP -0.03
  • FCCO -0.12
  • Stochastic Oscillator
  • IMMP 0.00
  • FCCO 1.67

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

Share on Social Networks: